Please provide your email address to receive an email when new articles are posted on . Medtronic announced that the FDA has approved its self-expanding transcatheter CoreValve System for patients ...
MINNEAPOLIS - Medtronic, Inc. today announced it has received Conformité Européenne (CE) Mark for valve-in-valve (VIV) procedures using the CoreValve® and CoreValve® Evolut(TM) transcatheter aortic ...
Approximately 1 in 3 patients with severe aortic stenosis who undergo transcatheter aortic valve implantation (TAVI) with the CoreValve device will require a permanent pacemaker within 30 days of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback